Skip to main content
Log in

XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The X-ray repair cross-complementing group 1 (XRCC1) gene, one of over 20 genes that participate in the base excision repair pathway, is thought to account for differences in susceptibility to hepatocellular carcinoma. To assess the relationship between the XRCC1 Arg399Gln polymorphism and the risk of hepatocellular carcinoma (HCC), we performed a meta-analysis. All the relevant studies were extracted from PubMed, Embase, the Chinese biomedicine databases, the Chinese national knowledge infrastructure, and the Wanfang databases (prior to August 2012). The meta-analysis was performed using all eligible studies, which covered a total of 2,554 cases and 3,320 controls, to examine the association between XRCC1 Arg399Gln polymorphism and the risk of HCC. Our analysis suggested that the variant genotypes of the XRCC1 Arg399Gln gene were associated with a significantly increased risk of HCC in a co-dominant model (Arg/Gln vs. Arg/Arg, odd ratios [OR] 1.39, 95 % confidence interval [CI] 1.08–1.79; Gln/Gln vs. Arg/Arg, OR 1.26, 95 % CI 1.04–1.52) and a dominant model (Arg/Gln + Gln/Gln vs. Arg/Arg OR 1.36, 95 % CI 1.07–1.72), whereas no association was observed in the recessive model (Gln/Gln vs. Arg/Gln + Arg/Arg, OR 1.05, 95 % CI 0.91–1.21). The results of the subgroup analysis by ethnicity indicated that the XRCC1 Arg399Gln polymorphism was associated with increased risk of HCC in Asian populations using the co-dominant model (Arg/Gln vs. Arg/Arg, OR 1.41, 95 % CI 1.06–1.87) and the dominant model (Gln/Gln vs. Arg/Gln + Arg/Arg, OR 1.35, 95 % CI 1.03–1.76). Our analysis provides evidence that the XRCC1 Arg399Gln polymorphism may be associated with a higher risk of HCC, especially among Asian populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ruggeri M (2012) Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review. Risk Manag Healthc Policy 5:49–54

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R (2004) The Gambia liver cancer study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39(1):211–219

    Article  PubMed  Google Scholar 

  3. Wu HC, Santella R (2012) The role of aflatoxins in hepatocellular carcinoma. Hepat Mon 12(10):e7238

    PubMed  PubMed Central  Google Scholar 

  4. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42(2):218–224

    Article  CAS  PubMed  Google Scholar 

  5. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP et al (2013) Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 45(1):72–75

    Article  CAS  PubMed  Google Scholar 

  6. Al-Qahtani A, Al-Anazi M, Viswan NA, Khalaf N, Abdo AA, Sanai FM, Al-Ashgar H, Al-Ahdal M (2012) Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis. PLoS ONE 7(9):e45128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yuan T, Wei J, Luo J, Liu M, Deng S, Chen P (2012) Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk. Dig Dis Sci 57(9):2451–2457

    Article  CAS  PubMed  Google Scholar 

  8. Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ, Li Z, Yang J et al (2012) GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 8(7):e1002791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW, Hu JJ (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190(2):183–190

    Article  CAS  PubMed  Google Scholar 

  10. Li Y, Liu F, Tan SQ, Wang Y, Li SW (2012) X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. PLoS ONE 7(9):e44441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Duman N, Aktan M, Ozturk S, Palanduz S, Cakiris A, Ustek D, Ozbek U, Nalcaci M, Cefle K (2012) Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (X-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia. Genet Test Mol Biomarkers 16(4):287–291

    Article  CAS  PubMed  Google Scholar 

  12. Bianchino G, Cittadini A, Grieco V, Traficante A, Zupa A, Improta G, Aieta M, Sgambato A (2011) Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study. Anticancer Res 31(4):1359–1365

    CAS  PubMed  Google Scholar 

  13. Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M (2011) XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int 31(6):802–809

    Article  CAS  PubMed  Google Scholar 

  14. Xie T, Wang ZG, Zhang JL, Liu H (2012) X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. World J gastroenterol 18(31):4207–4214

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Duan WH, Zhu ZY, Liu JG, Dong MS, Chen JZ, Liu QD, Xie Y, Sun TY, Gao ZF, Zhou NX (2012) XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Chinese Han population: a meta-analysis. Asian Pac J Cancer Prev 13(8):3601–3604

    Article  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  PubMed Central  Google Scholar 

  17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748

    CAS  PubMed  Google Scholar 

  19. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  CAS  PubMed  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Xu L (2003) A case-control study on association between genetic polymorphisms of DNA repair gene and primary liver cancer susceptibility. http://dwanfangdatacomcn/Thesis_Y556061aspx (article in Chinese). Accessed 15 June 2004

  22. Long X, Ma Y, Wei Y, Deng Z (2004) Polymorphism of DNA repair gene XRCC1 and risk of hepatocellular carcinoma. J Guangxi Med Univ 21(3):313–315 (article in Chinese)

    CAS  Google Scholar 

  23. Yang J, Han Y, Zheng S (2004) Influence of human XRCC1-399 nucleotide polymorphism primary hepatocytic carcinoma. Tumor 24(2):322–324 (article in Chinese)

    CAS  Google Scholar 

  24. Zt L (2005) The association between DNA repair gene polymorphism and aberrant methylation and hepatocelluar carcinoma. Available at Sun Yat-sen University Libraries (article in Chinese). Accession number: TN14058. Accessed 25 May 2005

  25. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW (2005) Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 34(6):1310–1318

    Article  PubMed  Google Scholar 

  26. Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R et al (2005) Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev 14(2):373–379

    Article  CAS  PubMed  Google Scholar 

  27. Borentain P, Gerolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, Le Treut YP, Berge-Lefranc JL, Gerolami R (2007) DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer 43(17):2479–2486

    Article  CAS  PubMed  Google Scholar 

  28. Ren X, Wang D, Li Z, Xin Y, Yin J, Zhang B, Ding H, Li N (2008) Study on the relationship between gene XRCC1 codon 399 single nucleotide polymorphisms and primary hepatic carcinoma in Han nationality. Chin J Clin Hepatol 24(5):361–365 (article in Chinese)

    Google Scholar 

  29. SU H (2008) A case-control study on association between genetic polymorphisms of DNA repair and hepatic cell cancer susceptibility. Available at http://dwanfangdatacomcn/Thesis_Y1300729aspx (article in Chinese)

  30. Kiran M, Saxena R, Chawla YK, Kaur J (2009) Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 327(1–2):7–13

    Article  CAS  PubMed  Google Scholar 

  31. Jia Z, Su H, Li X, Xu X, Yin Z (2010) Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China. Chin J Cancer Res 22(4):22–266 (article in Chinese)

    Article  Google Scholar 

  32. Zeng X, Yu H, Qiu X, Ji L, Li L (2010) A case-control study of polymorphism of XRCC1 gene and the risk of hepatocellular carcinoma. Chin J Control Prev 14(8):760–763 (article in Chinese)

    CAS  Google Scholar 

  33. Tang Y, Li X, Liu T, Yang J, Luo J, Li Z (2011) Genetic polymorphisms of DNA repair genes in patients with hepatocellular carcinoma. Shandong Med J 12(11):2947–2950 (article in Chinese)

    Google Scholar 

  34. Pan HZ, Liang J, Yu Z, Lun LM, Li H, Wang Q (2011) Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. APJCP 12(11):2947–2950

    PubMed  Google Scholar 

  35. Li QW, Lu CR, Ye M, Xiao WH, Liang J (2012) Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. APJCP 13(1):191–194

    PubMed  Google Scholar 

  36. Canalle R, da Silva SAV, Scrideli CA, de Paula Queiroz RG, Tone LG (2006) Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population. Environ Mol Mutagen 47(9):725–732

    Article  CAS  PubMed  Google Scholar 

  37. Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 13(4):583–591

    CAS  PubMed  Google Scholar 

  38. Ladiges W, Wiley J, MacAuley A (2003) Polymorphisms in the DNA repair gene XRCC1 and age-related disease. Mech Ageing Dev 124(1):27–32

    Article  CAS  PubMed  Google Scholar 

  39. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12):1513–1530

    CAS  PubMed  Google Scholar 

  40. Hu Z, Ma H, Chen F, Wei Q, Shen H (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14(7):1810–1818

    Article  CAS  PubMed  Google Scholar 

  41. Chen B, Zhou Y, Yang P, Wu XT (2012) Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep 39(2):1305–1313

    Article  CAS  PubMed  Google Scholar 

  42. Nissar S, Lone TA, Banday MZ, Rasool R, Chowdri NA, Parray FQ, Abdullah S, Sameer AS (2013) Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: a case control study. Oncol Lett 5(3):959–963

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Dai L, Duan F, Wang P, Song C, Wang K, Zhang J (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39(10):9535–9547

    Article  CAS  PubMed  Google Scholar 

  44. Kirkham JJ, Riley RD, Williamson PR (2012) A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews. Stat Med 31(20):2179–2195

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the National Natural Science Foundation of China (30872169) and the Natural Science Foundation of ShanDong Province, China (Contract No. ZR2011HM031).

Disclosures

The authors promised there were not any possible conflicts of interest in this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lianhua Cui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qi, Y., Cui, L., Song, Y. et al. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Mol Biol Rep 41, 879–887 (2014). https://doi.org/10.1007/s11033-013-2929-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-013-2929-0

Keywords

Navigation